Selected research
Industry Research
Acetylglucosamine Industry Research Report 2026
Market perspective
The global Acetylglucosamine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Acetylglucosamine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Acetylglucosamine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Acetylglucosamine include YSK, Fengrun Biotech, Golden-shell, Aoxin-group, Rixing Biotech, Bio-gen Extracts, AdvoCare, Amicogen and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Acetylglucosamine market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Acetylglucosamine Market by Company
YSK
Fengrun Biotech
Golden-shell
Aoxin-group
Rixing Biotech
Bio-gen Extracts
AdvoCare
Amicogen
Merck KGaA
Carl Roth
Kaneka
Ethical Naturals
NOW Foods
Beloor Bayir
Vitaco Health
Pure Encapsulations
Kraeber & Co
Source Naturals
NutriCology
Acetylglucosamine Segment by Type
Extraction of the Shell
Microbial Fermentation
Acetylglucosamine Segment by Application
Cosmetics
Health Care Products
Drugs
Others
Acetylglucosamine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acetylglucosamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acetylglucosamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acetylglucosamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Acetylglucosamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Acetylglucosamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Acetylglucosamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Extraction of the Shell
- Microbial Fermentation
Applications
- Cosmetics
- Health Care Products
- Drugs
- Others
Companies covered
- YSK
- Fengrun Biotech
- Golden-shell
- Aoxin-group
- Rixing Biotech
- Bio-gen Extracts
- AdvoCare
- Amicogen
- Merck KGaA
- Carl Roth
- Kaneka
- Ethical Naturals
- NOW Foods
- Beloor Bayir
- Vitaco Health
- Pure Encapsulations
- Kraeber & Co
- Source Naturals
- NutriCology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Acetylglucosamine Market Size (2021-2032)
- 2.2.2 Global Acetylglucosamine Sales (2021-2032)
- 2.2.3 Global Acetylglucosamine Market Average Price (2021-2032)
- 2.3 Acetylglucosamine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Extraction of the Shell
- 2.3.3 Microbial Fermentation
- 2.4 Acetylglucosamine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cosmetics
- 2.4.3 Health Care Products
- 2.4.4 Drugs
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Acetylglucosamine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Acetylglucosamine Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Acetylglucosamine Revenue of Manufacturers (2021-2026)
- 3.4 Global Acetylglucosamine Average Price by Manufacturers (2021-2026)
- 3.5 Global Acetylglucosamine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Acetylglucosamine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Acetylglucosamine, Product Type & Application
- 3.8 Global Manufacturers of Acetylglucosamine, Established Date
- 3.9 Global Acetylglucosamine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 YSK
- 4.1.1 YSK Company Information
- 4.1.2 YSK Business Overview
- 4.1.3 YSK Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 YSK Acetylglucosamine Product Portfolio
- 4.1.5 YSK Recent Developments
- 4.2 Fengrun Biotech
- 4.2.1 Fengrun Biotech Company Information
- 4.2.2 Fengrun Biotech Business Overview
- 4.2.3 Fengrun Biotech Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fengrun Biotech Acetylglucosamine Product Portfolio
- 4.2.5 Fengrun Biotech Recent Developments
- 4.3 Golden-shell
- 4.3.1 Golden-shell Company Information
- 4.3.2 Golden-shell Business Overview
- 4.3.3 Golden-shell Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Golden-shell Acetylglucosamine Product Portfolio
- 4.3.5 Golden-shell Recent Developments
- 4.4 Aoxin-group
- 4.4.1 Aoxin-group Company Information
- 4.4.2 Aoxin-group Business Overview
- 4.4.3 Aoxin-group Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Aoxin-group Acetylglucosamine Product Portfolio
- 4.4.5 Aoxin-group Recent Developments
- 4.5 Rixing Biotech
- 4.5.1 Rixing Biotech Company Information
- 4.5.2 Rixing Biotech Business Overview
- 4.5.3 Rixing Biotech Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Rixing Biotech Acetylglucosamine Product Portfolio
- 4.5.5 Rixing Biotech Recent Developments
- 4.6 Bio-gen Extracts
- 4.6.1 Bio-gen Extracts Company Information
- 4.6.2 Bio-gen Extracts Business Overview
- 4.6.3 Bio-gen Extracts Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bio-gen Extracts Acetylglucosamine Product Portfolio
- 4.6.5 Bio-gen Extracts Recent Developments
- 4.7 AdvoCare
- 4.7.1 AdvoCare Company Information
- 4.7.2 AdvoCare Business Overview
- 4.7.3 AdvoCare Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AdvoCare Acetylglucosamine Product Portfolio
- 4.7.5 AdvoCare Recent Developments
- 4.8 Amicogen
- 4.8.1 Amicogen Company Information
- 4.8.2 Amicogen Business Overview
- 4.8.3 Amicogen Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Amicogen Acetylglucosamine Product Portfolio
- 4.8.5 Amicogen Recent Developments
- 4.9 Merck KGaA
- 4.9.1 Merck KGaA Company Information
- 4.9.2 Merck KGaA Business Overview
- 4.9.3 Merck KGaA Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck KGaA Acetylglucosamine Product Portfolio
- 4.9.5 Merck KGaA Recent Developments
- 4.10 Carl Roth
- 4.10.1 Carl Roth Company Information
- 4.10.2 Carl Roth Business Overview
- 4.10.3 Carl Roth Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Carl Roth Acetylglucosamine Product Portfolio
- 4.10.5 Carl Roth Recent Developments
- 4.11 Kaneka
- 4.11.1 Kaneka Company Information
- 4.11.2 Kaneka Business Overview
- 4.11.3 Kaneka Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Kaneka Acetylglucosamine Product Portfolio
- 4.11.5 Kaneka Recent Developments
- 4.12 Ethical Naturals
- 4.12.1 Ethical Naturals Company Information
- 4.12.2 Ethical Naturals Business Overview
- 4.12.3 Ethical Naturals Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ethical Naturals Acetylglucosamine Product Portfolio
- 4.12.5 Ethical Naturals Recent Developments
- 4.13 NOW Foods
- 4.13.1 NOW Foods Company Information
- 4.13.2 NOW Foods Business Overview
- 4.13.3 NOW Foods Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 NOW Foods Acetylglucosamine Product Portfolio
- 4.13.5 NOW Foods Recent Developments
- 4.14 Beloor Bayir
- 4.14.1 Beloor Bayir Company Information
- 4.14.2 Beloor Bayir Business Overview
- 4.14.3 Beloor Bayir Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Beloor Bayir Acetylglucosamine Product Portfolio
- 4.14.5 Beloor Bayir Recent Developments
- 4.15 Vitaco Health
- 4.15.1 Vitaco Health Company Information
- 4.15.2 Vitaco Health Business Overview
- 4.15.3 Vitaco Health Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Vitaco Health Acetylglucosamine Product Portfolio
- 4.15.5 Vitaco Health Recent Developments
- 4.16 Pure Encapsulations
- 4.16.1 Pure Encapsulations Company Information
- 4.16.2 Pure Encapsulations Business Overview
- 4.16.3 Pure Encapsulations Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Pure Encapsulations Acetylglucosamine Product Portfolio
- 4.16.5 Pure Encapsulations Recent Developments
- 4.17 Kraeber & Co
- 4.17.1 Kraeber & Co Company Information
- 4.17.2 Kraeber & Co Business Overview
- 4.17.3 Kraeber & Co Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Kraeber & Co Acetylglucosamine Product Portfolio
- 4.17.5 Kraeber & Co Recent Developments
- 4.18 Source Naturals
- 4.18.1 Source Naturals Company Information
- 4.18.2 Source Naturals Business Overview
- 4.18.3 Source Naturals Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Source Naturals Acetylglucosamine Product Portfolio
- 4.18.5 Source Naturals Recent Developments
- 4.19 NutriCology
- 4.19.1 NutriCology Company Information
- 4.19.2 NutriCology Business Overview
- 4.19.3 NutriCology Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 NutriCology Acetylglucosamine Product Portfolio
- 4.19.5 NutriCology Recent Developments
5 Global Acetylglucosamine Market Scenario by Region
- 5.1 Global Acetylglucosamine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Acetylglucosamine Sales by Region: 2021-2032
- 5.2.1 Global Acetylglucosamine Sales by Region: 2021-2026
- 5.2.2 Global Acetylglucosamine Sales by Region: 2027-2032
- 5.3 Global Acetylglucosamine Revenue by Region: 2021-2032
- 5.3.1 Global Acetylglucosamine Revenue by Region: 2021-2026
- 5.3.2 Global Acetylglucosamine Revenue by Region: 2027-2032
- 5.4 North America Acetylglucosamine Market Facts & Figures by Country
- 5.4.1 North America Acetylglucosamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Acetylglucosamine Sales by Country (2021-2032)
- 5.4.3 North America Acetylglucosamine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Acetylglucosamine Market Facts & Figures by Country
- 5.5.1 Europe Acetylglucosamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Acetylglucosamine Sales by Country (2021-2032)
- 5.5.3 Europe Acetylglucosamine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Acetylglucosamine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Acetylglucosamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Acetylglucosamine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Acetylglucosamine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Acetylglucosamine Market Facts & Figures by Country
- 5.7.1 South America Acetylglucosamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Acetylglucosamine Sales by Country (2021-2032)
- 5.7.3 South America Acetylglucosamine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Acetylglucosamine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Acetylglucosamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Acetylglucosamine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Acetylglucosamine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Acetylglucosamine Sales by Type (2021-2032)
- 6.1.1 Global Acetylglucosamine Sales by Type (2021-2032) & (t)
- 6.1.2 Global Acetylglucosamine Sales Market Share by Type (2021-2032)
- 6.2 Global Acetylglucosamine Revenue by Type (2021-2032)
- 6.2.1 Global Acetylglucosamine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Acetylglucosamine Revenue Market Share by Type (2021-2032)
- 6.3 Global Acetylglucosamine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Acetylglucosamine Sales by Application (2021-2032)
- 7.1.1 Global Acetylglucosamine Sales by Application (2021-2032) & (t)
- 7.1.2 Global Acetylglucosamine Sales Market Share by Application (2021-2032)
- 7.2 Global Acetylglucosamine Revenue by Application (2021-2032)
- 7.2.1 Global Acetylglucosamine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Acetylglucosamine Revenue Market Share by Application (2021-2032)
- 7.3 Global Acetylglucosamine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Acetylglucosamine Value Chain Analysis
- 8.1.1 Acetylglucosamine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Acetylglucosamine Production Mode & Process
- 8.2 Acetylglucosamine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Acetylglucosamine Distributors
- 8.2.3 Acetylglucosamine Customers
9 Global Acetylglucosamine Analyzing Market Dynamics
- 9.1 Acetylglucosamine Industry Trends
- 9.2 Acetylglucosamine Industry Drivers
- 9.3 Acetylglucosamine Industry Opportunities and Challenges
- 9.4 Acetylglucosamine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst